Concepedia

Maarten Ooms

MO

Statistics

Publications

20

Citations

482

H-Index

15

Active since

2013

Affiliations

KU Leuven(Current)

Belgian Nuclear Research Centre

TRIUMF

Simon Fraser University

University of British Columbia

Maarten Ooms is an author at KU Leuven specializing in medicine, pharmacology, and biochemistry.

ORCID

Top concepts

Publications per year

2013–2024

20

Publications

20

Therapeutic Efficacy of <sup>213</sup>Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer

Yana Dekempeneer, Vicky Caveliers, Maarten Ooms et al. · Molecular Pharmaceutics · 2020 · 54 citations

Retention of [18F]fluoride on reversed phase HPLC columns

Dieter Ory, Jeroen Van den Brande, Tjibbe de Groot et al. · Journal of Pharmaceutical and Biomedical Analysis · 2015 · 52 citations

, , +1

Preclinical evaluation of [18F]JNJ42259152 as a PET tracer for PDE10A

Sofie Celen, Michel Koole, Maarten Ooms et al. · NeuroImage · 2013 · 40 citations

, , +6

Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6/2 Huntington mice

Maarten Ooms, Roma Rietjens, Janaki Raman Rangarajan et al. · Neurobiology of Aging · 2014 · 33 citations · Full text

, , +8

Synthesis and preclinical evaluation of [ 11 C]MA-PB-1 for in vivo imaging of brain monoacylglycerol lipase (MAGL)

Muneer Ahamed, Bala Attili, Daisy van Veghel et al. · European Journal of Medicinal Chemistry · 2017 · 31 citations · Full text

, , +6

Rows per page

1–5 of 20